MYELOPROLIFERATIVE NEOPLASM (MPN)
Clinical trials for MYELOPROLIFERATIVE NEOPLASM (MPN) explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASM (MPN) trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM (MPN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktails aim to tame deadly transplant complication
Disease control Recruiting nowThis study is for people with blood cancers who need a stem cell transplant from an unrelated donor with a different blood type. The goal is to find which drug combination works best to prevent graft-versus-host disease (GVHD), a serious complication where donor cells attack the …
Matched conditions: MYELOPROLIFERATIVE NEOPLASM (MPN)
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated May 26, 2026 11:31 UTC
-
Scientists hunt for immune clues to beat rare blood cancers
Knowledge-focused Recruiting nowThis study looks at how the immune system responds to myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect blood and bone marrow samples from 150 adults with MPN and healthy volunteers to find immune cells that recognize cancer cells. The g…
Matched conditions: MYELOPROLIFERATIVE NEOPLASM (MPN)
Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated May 26, 2026 11:35 UTC